Skip to content
Research platform
  • Company
    • About us
    • Team
  • Products
    • CNS tumour methylation classifier
    • Sarcoma methylation classifier
    • Skin cancer methylation classifier
  • Research
    • Methylation classification
    • Histology AI
  • News
  • Resources
    • Info materials
    • Publications
    • Events calendar
    • Frequently asked questions
Research platform
  • Company
    • About us
    • Team
  • Products
    • CNS tumour methylation classifier
    • Sarcoma methylation classifier
    • Skin cancer methylation classifier
  • Research
    • Methylation classification
    • Histology AI
  • News
  • Resources
    • Info materials
    • Publications
    • Events calendar
    • Frequently asked questions

Neuropathology

  • 2 July 2024

    DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifier

    A €4.3M seed round led by CARMA FUND I, with High-Tech Gründerfonds, LBBW Venture Capital and Start-up BW, to accelerate brain tumour classification.

AI-powered insights for precision oncology

Heidelberg Epignostix GmbH
c/o BioLabs Heidelberg
Nikola-Tesla-Straße 1
69124 Heidelberg

Company
  • About us
  • Team
  • News
  • Contact us
Products
  • CNS tumour classifier
  • Sarcoma classifier
  • Skin cancer classifier
Research
  • Methylation classification
  • Histology AI
  • Research platform
Resources
  • Info materials
  • Publications
  • Events calendar
  • Frequently asked questions
Legal notice
  • Privacy Policy
  • Imprint
  • Disclaimer
  • Terms of Use

© 2026 • Heidelberg Epignostix GmbH • All Rights Reserved

Page load link
Go to Top